Relevium in the News

Relevium Technologies Inc.
1000 Sherbrooke West, Suite 2700
Montreal, QC, H3A 3G4
(888) 528-8687
www.releviumtechnologies.com
info@releviumtechnologies.com

trading information

Market data is delayed by 15 minutes

Relevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory Matters

by Olga Tkach | September 11, 2019 | 2019 Press Releases | 0 Comments

MONTREAL, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the results of the Company's annual general and special meeting (the "AGM") held...

Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update

by Olga Tkach | August 1, 2019 | 2019 Press Releases | 0 Comments

MONTREAL, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company hit a record high in monthly sales in the month of July 2019 for its...

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients

by Ruiyang Liu | July 10, 2019 | 2019 Press Releases | 0 Comments

MONTREAL, July 10, 2019 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”), which...